Search research articles
Contact Us
Filters
Showing results (61-70 of 126) with videos related to
Page
of 13
Sort By:
Expert Opinion on Drug Safety
|
August 10, 2022
Analysis and visualization of the course and burden over time of adverse drug reactions (ADRs) attributed to TNFα-inhibitors in patients with inflammatory rheumatic diseases (IRDs)
Merel de Boer, Helen R Gosselt, Jurriaan Jansen, et al.
JAMA Dermatology
|
March 26, 2015
Developing a Therapeutic Range of Adalimumab Serum Concentrations in Management of Psoriasis: A Step Toward Personalized Treatment
Stef P Menting, Emma Coussens, Mieke F Pouw, et al.
Journal of Clinical Medicine
|
April 26, 2025
A Quality Analysis of the Measurement Properties of the Clinician-Reported Outcome Measures for Vitiligo and of the Studies Assessing Them: A Systematic Review
Jolien Duponselle, Sandrine Herbelet, Liesbeth Delbaere, et al.
Clinical and Experimental Dermatology
|
April 24, 2025
How do atopic dermatitis trialists perceive the HOME Core Outcome Set? - a survey study from the HOME initiative
Yuval Gilad, Eric L Simpson, Christian Apfelbacher, et al.
Journal of the American Academy of Dermatology
|
July 6, 2017
Discrepancy between the clinical and histopathologic diagnosis of soft tissue vascular malformations
Sophie E R Horbach, Amalia M Utami, Lorine B Meijer-Jorna, et al.
JAMA Dermatology
|
October 12, 2022
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative
Yael A Leshem, Joanne R Chalmers, Christian Apfelbacher, et al.
Acta Dermato-Venereologica
|
November 25, 2016
Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries
Paula Davila-Seijo, Ignacio Garcia-Doval, Luigi Naldi, et al.
The British Journal of Dermatology
|
December 20, 2023
How to use the Harmonising Outcome Measures for Eczema Core Outcome Set for atopic dermatitis trials: a users' guide
Kim S Thomas, Laura Howells, Yael A Leshem, et al.
The British Journal of Dermatology
|
October 4, 2023
Harmonization of outcomes in epidermolysis bullosa: report of the Core Outcome Sets for Epidermolysis Bullosa (COSEB) kick-off meeting
Eva W H Korte, Phyllis I Spuls, Peter C van den Akker, et al.
Archives of Dermatology
|
February 17, 2010
Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis
Lidian L A Lecluse, Rieke J B Driessen, Phyllis I Spuls, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 126) with videos related to
Sort By:
Page
of 13
Expert Opinion on Drug Safety
|
August 10, 2022
Analysis and visualization of the course and burden over time of adverse drug reactions (ADRs) attributed to TNFα-inhibitors in patients with inflammatory rheumatic diseases (IRDs)
Merel de Boer, Helen R Gosselt, Jurriaan Jansen, et al.
JAMA Dermatology
|
March 26, 2015
Developing a Therapeutic Range of Adalimumab Serum Concentrations in Management of Psoriasis: A Step Toward Personalized Treatment
Stef P Menting, Emma Coussens, Mieke F Pouw, et al.
Journal of Clinical Medicine
|
April 26, 2025
A Quality Analysis of the Measurement Properties of the Clinician-Reported Outcome Measures for Vitiligo and of the Studies Assessing Them: A Systematic Review
Jolien Duponselle, Sandrine Herbelet, Liesbeth Delbaere, et al.
Clinical and Experimental Dermatology
|
April 24, 2025
How do atopic dermatitis trialists perceive the HOME Core Outcome Set? - a survey study from the HOME initiative
Yuval Gilad, Eric L Simpson, Christian Apfelbacher, et al.
Journal of the American Academy of Dermatology
|
July 6, 2017
Discrepancy between the clinical and histopathologic diagnosis of soft tissue vascular malformations
Sophie E R Horbach, Amalia M Utami, Lorine B Meijer-Jorna, et al.
JAMA Dermatology
|
October 12, 2022
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative
Yael A Leshem, Joanne R Chalmers, Christian Apfelbacher, et al.
Acta Dermato-Venereologica
|
November 25, 2016
Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries
Paula Davila-Seijo, Ignacio Garcia-Doval, Luigi Naldi, et al.
The British Journal of Dermatology
|
December 20, 2023
How to use the Harmonising Outcome Measures for Eczema Core Outcome Set for atopic dermatitis trials: a users' guide
Kim S Thomas, Laura Howells, Yael A Leshem, et al.
The British Journal of Dermatology
|
October 4, 2023
Harmonization of outcomes in epidermolysis bullosa: report of the Core Outcome Sets for Epidermolysis Bullosa (COSEB) kick-off meeting
Eva W H Korte, Phyllis I Spuls, Peter C van den Akker, et al.
Archives of Dermatology
|
February 17, 2010
Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis
Lidian L A Lecluse, Rieke J B Driessen, Phyllis I Spuls, et al.
Page
of 13